Wrendon Timothy - 14 Feb 2025 Form 4 Insider Report for OXBRIDGE RE HOLDINGS Ltd (OXBR)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Feb 2025, 16:04:55 UTC
Prior SEC filing
17 Apr 2024
Next SEC filing
30 Sep 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Wrendon Timothy

Key filing fact

Wrendon Timothy filed Form 4 for OXBRIDGE RE HOLDINGS Ltd (OXBR) on 20 Feb 2025.

Key facts

  • This page summarizes Wrendon Timothy's Form 4 filing for OXBRIDGE RE HOLDINGS Ltd (OXBR).
  • 4 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 20 Feb 2025, 16:04.

Change

  • Previous filing in this sequence was filed on 17 Apr 2024.
  • Current net transaction value: -$2.8.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OXBR transaction

Ordinary Shares

Award

Transaction value
$0
Shares
+25,000
Change %
+33%
Price
$0.000000
Shares after
100,050
Date
14 Feb 2025
Ownership
Direct
Footnotes
F1
OXBR transaction

Ordinary Shares

Options Exercise

Transaction value
$180,000
Shares
+90,000
Change %
+90%
Price
$2.00
Shares after
190,050
Date
14 Feb 2025
Ownership
Direct
Footnotes
F2
OXBR transaction

Ordinary Shares

Tax liability

Transaction value
$180,003
Shares
-35,020
Change %
-18%
Price
$5.14
Shares after
155,030
Date
14 Feb 2025
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OXBR transaction Derivative

Share Options (right to buy)

Options Exercise

Transaction value
$0
Shares
-90,000
Change %
-100%
Price
$0.000000
Shares after
0
Date
14 Feb 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
90,000
Exercise price
$2.00
Footnotes
F2
OXBR holding Derivative

Share Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
75,000
Date
14 Feb 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
75,000
Exercise price
$6.00
Footnotes
F3
OXBR holding Derivative

Share Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,000
Date
14 Feb 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
10,000
Exercise price
$6.06
Footnotes
F3
OXBR holding Derivative

Share Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,000
Date
14 Feb 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
10,000
Exercise price
$6.00
Footnotes
F3
OXBR holding Derivative

Warrants to Purchase Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
7,500
Date
14 Feb 2025
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
7,500
Exercise price
$7.50
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents grant of restricted ordinary shares under the Issuer's 2021 Omnibus Incentive Plan.

Footnote F2

Represents a "net exercise" of 90,000 outstanding share options. 35,020 shares were withheld by the company for payment of the exercise price at a share price of $5.14. The remaining net 54,980 ordinary shares were issued to, and retained by, the reporting person.

Footnote F3

These share options are currently exercisable and vested in increments of 6.25% each on a quarterly basis, commencing on the date granted, and continuing on April 1st, July 1st, October 1st and January 1st of each calendar year, over a four-year period.

Footnote F4

Currently exercisable.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .